Blanket Purchase Agreement FA860119A0008

The Centers for Disease Control and Prevention (CDC) awarded a Blanket Purchase Agreement (BPA) to Life Technologies Corporation, a for-profit manufacturer of scientific instruments, reagents, and consumables. The single-award BPA, valued at $0.00, runs from September 1, 2020 to August 24, 2022 and is for the procurement of reagents and consumables required to operate 3130XL and 3500XL Genetic Analyzers at the CDC's sequencing core facility. Life Technologies was awarded this sole-source...

The Department of Health and Human Services Food and Drug Administration (FDA) awarded an Indefinite Delivery Contract (IDC) to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents, for the provision of Reagent (Chemistry) Kits. The single-award IDC has a ceiling value of $19,500,000 and an ultimate completion date of September 14, 2022. Under this contract, the FDA has issued a series of firm fixed-price delivery orders to Illumina for the supply of various chemistry...

The U.S. Food and Drug Administration (FDA) has awarded a $1 million single-award Indefinite Delivery, Indefinite Quantity (IDIQ) contract to Pacific Biosciences of California, Inc. to provide sequencing reagents, kits, and consumables to support the agency's genomic research and regulatory review activities. Under this contract, the FDA has issued multiple delivery orders for the purchase of Pacific Biosciences' proprietary single molecule, real-time (SMRT) sequencing consumables, including...

The Blanket Purchase Agreement (BPA) awarded by the DOD Uniformed Services University of the Health Sciences to Life Technologies Corporation provides MICR RNA kits with a potential value of $150,000.00. As the prime contractor, Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables, will deliver these products to support the agency's research and healthcare mission. The BPA does not utilize any set-asides, and was awarded on December 1, 2013 with a...

The Defense Health Agency awarded a blanket purchase agreement to Qiagen, LLC for reagents, consumables, and related laboratory supplies. The single award BPA has a potential value of $8 million and a period of performance through February 2025. Two firm fixed price call contracts were subsequently awarded against the BPA, the first for $60,041 worth of reagents and peripherals consumables to be delivered to Bethesda, Maryland by September 2021. The second call contract was for $125,000 of...

The Department of the Army Medical Command awarded a blanket purchase agreement to Life Technologies Corporation for the procurement of reagents, consumables, equipment, and maintenance services in support of various medical research and healthcare programs. Over the period of performance from July 2020 to January 2023, task orders valued at a total of $199,000 were placed against this agreement for the delivery of products such as genetic analyzers, polymer materials, centrifuge plates, and gel...

This indefinite delivery contract was awarded by the National Heart Lung and Blood Institute, a civilian agency of the U.S. federal government, to the prime contractor Applied Biosystems, LLC, a subsidiary of Life Technologies Corporation. The contract, valued at a ceiling of $222,903.87, is for the delivery of laboratory equipment and supplies to support the agency's specialized research and healthcare mission. The award leverages Applied Biosystems' expertise as a manufacturer of genetic...

The Department of the Army Medical Command awarded a blanket purchase agreement to Illumina, Inc. to provide sequencing consumables, equipment, and maintenance services in support of various research and medical programs. Under multiple firm fixed price call orders valued collectively at over $2 million, Illumina will deliver reagents, kits, and support plans for NextSeq and MiSeq sequencing systems located in Maryland, California, and elsewhere. The orders facilitate ongoing genomic research by...

The Defense Health Agency awarded a $5 million single-award Blanket Purchase Agreement to Integrated DNA Technologies, Inc. (IDT), effective September 17, 2024, through September 16, 2029. IDT, headquartered in Coralville, Iowa, is a leading manufacturer of specialized nucleic acid products including custom DNA and RNA oligonucleotides, gene fragments, sequencing products, primers, and probes. The BPA was awarded without set-aside designation, allowing IDT to compete in open market...

The Department of the Army Medical Command awarded a single-award Blanket Purchase Agreement (BPA) to Life Technologies GMBH, a foreign-owned manufacturer and subsidiary of Thermo Fisher Scientific, valued at $4.5 million with an ultimate completion date of April 23, 2025. The BPA, solicited in February 2020 and awarded on April 24, 2020, establishes an indefinite delivery vehicle for the procurement of reagents and related laboratory supplies to support the Army's medical programs. All work...